Evidence map›Paper›PMID 39819221›Full record

ArticleStatistical methods in medical research2025

Adjusting for switches to multiple treatments: Should switches be handled separately or combined?

Helen Bell Gorrod, Shahrul Mt-Isa, Jingyi Xuan, Kristel Vandormael, William Malbecq, Victoria Yorke-Edwards, Ian R White, Nicholas Latimer

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [A comparative study of different methods for treatment switching analysis in clinical trials].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Helen Bell GorrodSheffield Centre for Health and Related Research, School of Medicine and Population Health, University of Sheffield, Sheffield, South Yorkshire, UK.ORCID 0000-0001-8054-8073
Shahrul Mt-IsaBiostatistics and Research Decision Sciences (BARDS) Health Technology Assessment (HTA) Statistics, MSD, Zurich, Switzerland.
Jingyi XuanMRC Clinical Trials Unit at UCL, University College London, London, UK.ORCID 0000-0002-5721-4857
Kristel VandormaelBiostatistics and Research Decision Sciences (BARDS) Health Technology Assessment (HTA) Statistics, MSD, Brussels, Belgium.
William MalbecqStatistique mathématique et Probabilités, Université libre de Bruxelles, Bruxelles, Belgium.
Victoria Yorke-EdwardsCentre for Advanced Research Computing, University College London, London, UK.ORCID 0000-0002-6465-7330
Ian R WhiteMRC Clinical Trials Unit at UCL, University College London, London, UK.
Nicholas LatimerSheffield Centre for Health and Related Research, School of Medicine and Population Health, University of Sheffield, Sheffield, South Yorkshire, UK.ORCID 0000-0001-5304-5585

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment switching is common in randomised controlled trials (RCTs). Participants may switch onto a variety of different treatments, all of which may have different treatment effects. Adjustment analyses that target hypothetical estimands - estimating outcomes that would have been observed in the absence of treatment switching - have focused primarily on a single type of switch. In this study, we assess the performance of applications of inverse probability of censoring weights (IPCW) and two-stage estimation (TSE) which adjust for multiple switches by either (i) adjusting for each type of switching separately ('treatments separate') or (ii) adjusting for switches combined without differentiating between switched-to treatments ('treatments combined'). We simulate 48 scenarios in which RCT participants may switch to multiple treatments. Switch proportions, treatment effects, number of switched-to treatments and censoring proportions were varied. Method performance measures included mean percentage bias in restricted mean survival time and the frequency of model convergence. Similar levels of bias were produced by treatments combined and treatments separate in both TSE and IPCW applications. In the scenarios examined, there was no demonstrable advantage associated with adjusting for each type of switch separately, compared with adjusting for all switches together.

Indexed as

Randomized Controlled Trials as TopicBiasHumansModels, StatisticalTreatment Outcomecounterfactualhealth technology assessmentmultiple treatmentsoncologyoverall survivalsurvival analysistime-dependent confoundingtime-to-event outcomesTreatment switching

Identifiers

PMID39819221
PMCPMC11874486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.